Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer

Figure 7

Representative ROC curves between early-stage NSCLC, LBD, and HC. (a) Panel a for differentiating early-stage NSCLC from HC. (b) Panel b for differentiating LBD from HC. (c) Panel c for differentiating early-stage NSCLC from LBD. NSCLC, non-small cell lung cancer; LBD, lung benign disease; HC, healthy controls.

(a)

(b)

(c)